best performing large cap stock between nov 2013 and oct 2015

Neurocrine Biosciences (NBIX) had the highest return between November 1, 2013 and October 31, 2015 by a large-cap US stock, returning 420%.

ASSET DATE % RETURN
Neurocrine Biosciences (NBIX)
11/1/2013 - 10/31/2015
420.02%
Celsius (CELH)
11/1/2013 - 10/31/2015
419.06%
Palo Alto Networks (PANW)
11/1/2013 - 10/31/2015
282.24%
Skyworks Solutions (SWKS)
11/1/2013 - 10/31/2015
202.49%
Incyte (INCY)
11/1/2013 - 10/31/2015
201.05%
DexCom (DXCM)
11/1/2013 - 10/31/2015
190.82%
Broadcom (AVGO)
11/1/2013 - 10/31/2015
176.87%
Electronic Arts (EA)
11/1/2013 - 10/31/2015
174.66%
Manhattan Associates (MANH)
11/1/2013 - 10/31/2015
174.03%
Southwest Airlines (LUV)
11/1/2013 - 10/31/2015
172.2%
Royal Caribbean Cruises (RCL)
11/1/2013 - 10/31/2015
142.03%
Edwards Lifesciences (EW)
11/1/2013 - 10/31/2015
140.14%
Monster Beverage (MNST)
11/1/2013 - 10/31/2015
136.87%
Expedia (EXPE)
11/1/2013 - 10/31/2015
134.93%
Netflix (NFLX)
11/1/2013 - 10/31/2015
130.72%
Global Payments (GPN)
11/1/2013 - 10/31/2015
129.34%
Genmab A-S (GMAB)
11/1/2013 - 10/31/2015
125.29%
NetEase (NTES)
11/1/2013 - 10/31/2015
121.67%
O’Reilly Automotive (ORLY)
11/1/2013 - 10/31/2015
121.34%
Frank's International (FI)
11/1/2013 - 10/31/2015
118%
Centene (CNC)
11/1/2013 - 10/31/2015
112.58%
Paycom Soft (PAYC)
11/1/2013 - 10/31/2015
112.35%
Constellation Brands Inc Class A (STZ)
11/1/2013 - 10/31/2015
107.03%
AerCap (AER)
11/1/2013 - 10/31/2015
104.43%
U-Haul (UHAL)
11/1/2013 - 10/31/2015
103.97%
Large-cap stocks are treated as having a market cap of $10B+.